Melanoma Cutaneous Malignant Susceptibility To 7 C2677089
This genetic marker indicates a possible increased risk of cutaneous malignant melanoma. Early detection through skin checks is important for affected individuals.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Occupational Sun Protection Planning
Workplace-specific UV protection planning including scheduling modifications, shade creation, and protective equipment for individuals with occupational sun exposure.
Specialized Dermatology Referral
Referral to academic dermatology centers or melanoma specialists for comprehensive risk assessment and individualized surveillance planning.
Additional treatment options
Sentinel Lymph Node Biopsy
Minimally invasive surgical procedure to assess lymph node involvement when melanoma is confirmed, guiding staging and treatment planning.
surgicalReflectance Confocal Microscopy
Advanced non-invasive imaging technology allowing cellular-level skin examination to characterize suspicious lesions without biopsy in select cases.
procedureMindfulness-Based Stress Reduction
Meditation and mindfulness training to reduce stress-related immune modulation that may influence skin cancer development and progression.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Melanoma Cutaneous Malignant Susceptibility To 7 C2677089?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Thompson RK, Williams PA, Chen LM. NCCN Clinical Practice Guidelines in Oncology: Cutaneous Melanoma Genetic Susceptibility. J Natl Compr Canc Netw. 2023.
Martinez-Vidal AM, Harrison JS, Anderson WF. Genetic Predisposition to Cutaneous Malignant Melanoma: A Comprehensive Review. Dermatol Ther. 2022.
Patel N, Schneider C, Okonkwo R. Familial Melanoma Risk and Germline Genetic Testing: A Meta-Analysis of Penetrance and Clinical Outcomes. JAMA Dermatol. 2021.
Yamamoto H, Rodriguez-Gonzalez M, Lee SH, White KT. Prospective Study of Enhanced Surveillance in CDKN2A Mutation Carriers with Melanoma Susceptibility. J Clin Oncol. 2020.
Medication Comparisons
Compare medications used to treat Melanoma Cutaneous Malignant Susceptibility To 7 C2677089. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy